Daniella Beckman
Daniella Beckman's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2024
Daniella Beckman has no open-market purchase on record since 2024. Sales in 2 of the 3 years since 2024.
Daniella Beckman reported 0 open-market purchases and 4 sales since 2024; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 2×2 trades |
| 2024 | — | 2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Daniella Beckman's trades
Has Daniella Beckman bought shares on the open market?
Daniella Beckman has no open-market purchase on record since 2024. Sales in 2 of the 3 years since 2024.
When did Daniella Beckman last buy or sell shares?
In SEC filings since 2024: no open-market purchase is on record; the latest open-market sale is from 2025.
Which companies has Daniella Beckman traded as an insider?
Tango Therapeutics (TNGX), from 2024 to 2025: 0 purchases and 4 sales.